Short answer
AVITA Medical, Inc. (RCEL) filed an 8-K current report with the SEC on June 4, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders). Annual meeting quorum established with 15,592,447 shares voting out of 30,776,689 outstanding.
AVITA Medical, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Annual meeting quorum established with 15,592,447 shares voting out of 30,776,689 outstanding
- Stockholders approved option and restricted-stock-unit grants for non-executive directors
- Equity awards increase director compensation and create potential future dilution for shareholders
Item 5.07 · Submission of Matters to a Vote of Security Holders
- All seven director nominees elected, with affirmative votes ranging from 10.7M to 11.2M
- Non-executive director cash fee pool increased 20%, from $750,000 to $900,000 annually
- Director equity grants approved, including 22,214 RSUs and 16,133 options annually per director
- Perceptive warrant issuance approved for up to 650,000 shares with a 10-year term, creating potential dilution
- Shareholders approved additional ASX issuance capacity of up to 10% of issued capital and annual executive-compensation votes
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other AVITA Medical, Inc. 8-K filings
Get the next RCEL 8-K as it lands
Follow RCEL for push alerts, or ask the research agent what this filing means.